Clinical Updates from San Antonio - HR+/HER2- Breast Cancer: CDK 4/6 Inhibitors Evaluation (ID: i851-6) Survey

1.How many years have you been in practice?(Required.)

<1

1-10

11 - 20

≥21

2.How many patients with breast cancer do you manage per week?(Required.)

1 to 10 

11 to 25

26 to 50

I am not directly involved in patient care

3.Please select the option that best describes your practice setting.(Required.)

Academic medical center

Community medical center

Research

4.After participating in this activity, how confident are you in the management of patients with breast cancer in your practice?(Required.)

5.How committed are you to making changes in your practice based on your participation in this activity?(Required.)

If not committed or do not plan to make changes, please indicate reason:

6.Which of the following best describes the impact of this activity on your performance?(Required.)

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

7.Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.(Required.)

Increased ability to identify key clinical trial data

Improved awareness of emerging clinical trial results that will affect clinical practice

Greater familiarity with biomarkers in the selection of treatment for breast cancer

Increased understanding of neoadjuvant, adjuvant, first-line, or subsequent-line treatment for patients with breast cancer

8.What barriers do you see to making changes in your practice? Please select all that apply.(Required.)

Lack of knowledge regarding evidence-based strategies 

Lack of convincing evidence to warrant change 

Lack of time/resources to consider change 

Insurance, reimbursement, or legal issues 

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

9.Please rate your level of agreement by checking the appropriate rating.

After participating in today's activity, I am now better able to:(Required.)

Strongly agree

Agree

Neutral

Disagree

Strongly disagree

Compare and contrast new and emerging therapies with established treatment options for patients with breast cancer

Strongly agree

Agree

Neutral

Disagree

Strongly disagree

14.If you indicated that you perceived commercial bias or influence, please describe:

15.As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

16.Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities about breast cancer: